Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For FROG
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 3.55 2.55 2.46
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -24.28 4.09 5.40
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.55 6.61 6.45
Cash 4.65 5.42 5.18
Capex -33.90 < 0.005 < 0.005
Free Cash Flow -48.83 0.16 0.30
Revenue 1.48 0.94 0.92
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 0.11 0.79 0.79
Operating Margin -3.49 -0.16 -0.16
ROA 23.67 < 0.005 -0.01
ROE 24.92 -0.01 -0.02
ROIC 24.40 -0.02 -0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of FROG is permitted for members.
5 Growth
The "Growth Entry" for the Focus of FROG is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of FROG is permitted for members.